Last edition
News about "inflammation "
Gilead Sciences Opens 182,000-Sq-Ft Research Centre at Foster City Headquarters
Gilead Sciences has opened a 182,000-square-foot research centre in Foster City, expanding its capabilities in oncology, inflammation and research data science.
Inflammation | 10/09/2026 | By News Bureau
Tangram Therapeutics Advances TGM-312 into MASH Patient Cohorts in Phase 1/2 Trial
Tangram Therapeutics advances TGM-312 into MASH patient cohorts in its Phase 1/2 RESTORE-MASH trial while appointing Dr Sonya Montgomery as Chief Development Officer to drive its clinical pipeline.
Inflammation | 05/09/2026 | By News Bureau
US FDA approves Viridian's Lumvoa for treatment of thyroid eye disease
Viridian Therapeutics secures US FDA approval for Lumvoa, the first IGF-1R antagonist approved to treat both active and chronic thyroid eye disease, with commercial launch set to begin immediately.
Inflammation | 30/06/2026 | By News Bureau | 103
AbbVie Announces Acquisition of Celsius Therapeutics
AbbVie has acquired Celsius Therapeutics, Inc., a privately held biotechnology company pioneering new therapies for patients with inflammatory disease.
Inflammation | 29/06/2024 | By Aishwarya | 1050
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy